Asia
Shares of Eagle Pharmaceuticals and Teva Pharmaceuticals are climbing following a favorable ruling in U.S. District Court that protects the patent for cancer drug Bendeka from generic competition through 2031.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 29, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 27, 2020.
“Our goal is to successfully treat patients with severe inflammatory conditions and this is now possible through our alliance with Takeda,” said Denice Spero, president and chief business officer of ProThera.
Despite the domination of the news cycle by the COVID-19 pandemic, quite a number of biopharma companies reported on non-COVID-19 clinical trials last week, although there remains plenty of ongoing trial news related to the pandemic. Here’s a look.
Although promising, it’s still unclear if this would actually prevent infection in people.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 24, 2020.
Biopharma and life sciences companies bolster their leadership teams and boards with this week’s Movers & Shakers.
Plurisitem Therapeutics’ PLX (Placental eXpanded) cells are showing promise as a therapy for patients with severe cases of COVID-19.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
PRESS RELEASES